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Abstract
Background: Cigarette smoke (CS) is a highly complex mixture and many of its components are known carcinogens,
mutagens, and other toxic substances. CS induces oxidative stress and cell death, and this cell toxicity plays a key role in the
pathogenesis of several pulmonary diseases.
Methodology/Principal Findings: We studied the effect of cigarette smoke extract (CSE) in human alveolar epithelial type I-
like (ATI-like) cells. These are isolated type II cells that are differentiating toward the type I cell phenotype in vitro and have
lost many type II cell markers and express type I cell markers. ATI-like cells were more sensitive to CSE than alveolar type II
cells, which maintained their differentiated phenotype in vitro. We observed disruption of mitochondrial membrane
potential, apoptosis and necrosis that were detected by double staining with acridine orange and ethidium bromide or
Hoechst 33342 and propidium iodide and TUNEL assay after treatment with CSE. We also detected caspase 3 and caspase 7
activities and lipid peroxidation. CSE induced nuclear translocation of Nrf2 and increased expression of Nrf2, HO-1, Hsp70
and Fra1. Moreover, we found that Nrf2 knockdown sensitized ATI-like cells to CSE and Nrf2 overexpression provided
protection against CSE-induced cell death. We also observed that two antioxidant compounds N-acetylcysteine and trolox
protected ATI-like cells against injury by CSE.
Conclusions: Our study indicates that Nrf2 activation is a major factor in cellular defense of the human alveolar epithelium
against CSE-induced toxicity and oxidative stress. Therefore, antioxidant agents that modulate Nrf2 would be expected to
restore antioxidant and detoxifying enzymes and to prevent CS-related lung injury and perhaps lessen the development of
emphysema.
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Introduction
Cigarette smoke (CS) is a highly complex mixture and many of
its components are known carcinogens, mutagens, and other toxic
substances. In the United States, over 400,000 deaths per year are
attributed to smoking. CS is a complex chemical aerosol composed
of particulates suspended in a gaseous phase [1]. The tar particles
in the smoke are of different sizes and the smallest particles have
the greatest potential to reach deep into the lung. The pulmonary
epithelium is the barrier between inhaled air and the underlying
tissue. Type I cells compose 95% of the alveolar surface in the
distal gas exchange region of the lung. To maintain this barrier,
continuous cell replacement and repair of the epithelium are
important. Cell death through apoptosis is essential for eliminating
damaged cells during tissue remodeling and inflammation. Dis-
turbance of this physiological process can however, result in
necrosis or excessive apoptosis with disruption of the barrier func-
tion of the epithelium, leading to lung injury and the development
of emphysema [2]. Emphysema develops because of destruction of
the alveolar wall and damage to the alveolar epithelium and
underlying microvasculature. The pathogenesis of emphysema has
traditionally focused on the protease imbalance as exemplified by
alpha-1-antitrypsin deficiency and the resultant destruction of the
extracellular matrix, especially elastin fibers [3,4]. However, more
recently attention has been given to a complementary hypothesis
of cellular injury and resultant apoptosis due to oxidants in CS or
those induced by cigarette smoke extract (CSE) [5]. The two most
sensitive cells to oxidant injury in the alveolar septum are type I
alveolar epithelial cells and microvascular endothelial cells. Recent
studies have shown an increase in apoptotic cells in the lungs of
patients with chronic obstructive pulmonary disease (COPD) [6].
Most of the apoptotic cells were alveolar epithelial cells and not
microvascular endothelial cells. The majority of the apoptotic
epithelial cells were thought to be alveolar type II (ATII) cells, but
this could have been due in part to a sampling error in that type I
cells are very large and flat and pathologic sections might easily
miss the nucleus of apoptotic type I cells. Currently we know very
little about the susceptibility of human alveolar epithelilal cells to
CS or the regulation of the antioxidant defenses.
Phase 2 detoxifying enzymes are classified as ‘‘indirect’’
antioxidant enzymes due to their role in redox balance and thiol
homeostasis [7,8,9]. Nuclear factor-erythroid 2 related factor 2
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(bZIP) transcription factor family. Nrf2 is constitutively expressed
in almost all cell types and tissues but is most abundant in tissues
where routine detoxification reactions occur normally, including
lung, intestine, and kidney. Under basal conditions, Nrf2 is se-
questered in the cytoplasm by Kelch-like ECH-associated protein 1
(Keap1). Nrf2 is known to be activated by phosphorylation via
several protein kinase pathways leading to Keap1NNrf2 dissociation
and nuclear translocation. Nrf2 exerts its role in host protection
against oxidative injury and carcinogenesis via binding to cis-acting
promoter sequences, called antioxidant response elements (AREs),
which leads to induction of numerous ARE-bearing antioxidant/
defense and cytoprotective genes. Pulmonary Nrf2 effector genes
bearing AREs include phase 2 antioxidant/detoxifying enzymes as
well asstressproteinssuchasheme oxygenase1 (HO-1)[7,8,9]. The
alveolar epithelium is exposed to high levels of free radicals which
are present in smoke and can damage cellular macromolecules [9].
HO-1 plays a central role in the defense against lung oxidative and
inflammatory insults, including CS exposure [10] and its overex-
pression protects against oxidative stress [11]. CS enhances expres-
sion of Nrf2 and phase 2-related genes regulated by Nrf2. This was
shown in vivo in mice that lack the Nrf2 gene, which indicates that
the activation of Nrf2 may represent a key cytoprotective response
mechanism against cell injury induced by CS [12]. It is important to
note inthiscontext that Nrf2targetingmight provideclinicalbenefit
by reducing both oxidative stress and inflammation in emphysema
[13].
Therefore in this study we focused on two antioxidants N-
acetylcysteine (NAC) and trolox that have been found to reduce
oxidative stress and inflammation. NAC is a membrane-permeable
thiolic compound that contains a sulfhydryl group donor, serving
as a precursor of glutathione (GSH) synthesis and inhibits the
formation of reactive oxygen species (ROS) [14,15]. NAC has
been shown to exhibit protective effects against DNA oxidative
damage by its antioxidant properties [16,17]. It was also reported
that NAC attenuates pulmonary emphysema and alveolar septal
cell apoptosis in vivo in rats [18] and reduced air trapping in
patients with moderate to severe emphysema [19]. Trolox is a
water soluble derivative of vitamin E and is part of a family of
essential micronutrients comprising lipid-soluble tocopherols and
tocotrienols with potent antioxidant activities [20]. This com-
pound has been reported to be an excellent antioxidant in vitro
[21]. Furthermore, acute exacerbations of emphysema induce
oxidative stress [22], which may be decreased by trolox. Therefore
we focused in this study on the alveolar cell injury by CSE, the role
of Nrf2 and antioxidant defense system.
Although alveolar type I cells are the likely target of oxidants in
CS because of their large surface area and sensitivity to oxidant
injury, they are difficult to study. Human alveolar type I cells have
not been isolated for in vitro studies to our knowledge. We have
chosen to use alveolar type I-like (ATI-like) cells which are ATII
cells that are transitioning to become type I cells in that they no
longer express the surfactant proteins, SP-A, SP-B and SP-C but
do express type I cell markers caveolin and receptor for advanced
glycation end products (RAGE) [23]. The purpose of this project
was to determine the susceptibility of ATI-like cells to CSE, the
role of Nrf2 in protecting ATI-like cells to injury, and efficiency of
antioxidant compounds NAC and trolox to protect ATI-like cells
to injury due to CS. There is no previous study on the role of Nrf2
protecting human ATI-like cells. We hypothesize that Nrf2 will
play an important role in preventing injury to alveolar epithelial
cells by CSE. We also expect that antioxidant compounds NAC
and trolox will provide protection.
Results
CSE Induces Both Apoptosis and Necrosis in ATI-like Cells
In our initial experiments we compared the toxicity induced by
CSE in both differentiated ATII cells and ATI-like cells (Figure
S1A, B). As measured by propidium iodine staining, ATI-like cells
were significantly more sensitive than ATII cells after treatment
with 10% CSE for 24 h. We had found previously the same
correlation that ATI-like cells were more sensitive than ATII cells
to ozone [24]. We chose the CSE concentrations to study acute
toxicity based on ATI-like cell double staining with acridine
orange and ethidium bromide to distinguish between live, early
and late apoptotic cells and necrotic cells (Figure 1, Panel I, A, B,
C). Our time points were chosen on the basis of preliminary data.
We found more apoptotic cells than necrotic cells after ATI-like
cell treatment with CSE for 4 h and more necrotic cells after 24 h
treatment. These results indicate that CSE induces both apoptosis
and necrosis in a time- and concentration-dependent manner in
ATI-like cells.
We observed chromatin condensation and fragmentation in
ATI-like cells after treatment with CSE using TUNEL assay
(Figure 1, Panel II, A, B, C). The percentage of apoptotic cells
increased in a concentration and time-dependent manner. We
observed the highest induction of apoptosis (5.8%) after 24 h
treatment with CSE. We found a statistically significant increase in
apoptotic ATI-like cells after 24 h exposure to all applied
concentrations of CSE and after 4 h of treatment with 5% and
10% CSE. We then used a caspase activity assay to further define
the apoptosis pathway induced by CSE (Figure 1, Panel III). These
results suggest a caspase-dependent apoptosis pathway induced by
CSE in ATI-like cells.
CSE Induces Lipid Peroxidation in ATI-like Cells
Immunostaining with 4-HNE, which is a specific and stable
product of lipid peroxidation, was used to detect oxidative stress
induced by CSE in ATI-like cells (Figure 2A, B). This exposure
induced cellular immunocytofluorescence for 4-HNE in compar-
ison with control. We observed an increase in the intensity of
cytoplasmic and nuclear staining. These data suggest that CSE
increases 4-HNE production as a consequence of oxidative stress,
and this observation is consistent with our other results confirming
that CSE is a strong activator of ROS-induced protein expression.
CSE Induces Nrf2 Translocation
Because CSE induces cell injury and oxidative stress, we wanted
to determine if the main regulator of defense against oxidant stress,
the transcription factor Nrf2 was activated. We used immunocyto-
fluorescence to determine the effect of CSE on Nrf2 localization in
ATI-like cells. We observed the highest nuclear translocation of
Nrf2 between 1.5 h to 4 h after these cells were exposed to 5%
CSE in comparison with control (Figure 3A, B). This translocation
was lower after cell treatment with 5% CSE for 24 h (data not
shown). This observation suggests that CSE induces ATI-like cell
antioxidant response through an Nrf2-dependent mechanism but
it is not sustained.
NAC and Trolox Protect ATI-like Cells Against CSE
Because of the sensitivity of ATI-like cells to the cytotoxic effects
of CSE (Figure S1), we applied NAC and trolox in ATI-like cells in
vitro. Also because of their surface area type I cells would be likely
the prime targets of CS in the alveolar region. To determine if
antioxidant compounds NAC and trolox would block the cell injury
induced by CSE, we initially tested the effect on cell viability. We
used the MTT assay (Data S1) to determine non-toxic concentrations
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treatment of ATI-like cells with 5 mM NAC or trolox, respectively.
Therefore, we selected this concentration for both antioxidant
compounds for all subsequent experiments.
We found that co-treatment with CSE and 5 mM trolox
statistically reduced cell necrosis in comparison with all applied
concentrations of CSE. We also found that 5 mM NAC significantly
reduced necrosisof ATI-likecells to5%or10%CSE(Figure 4A, B).
Treatment with either 5 mM NAC or 5 mM trolox prevented the
nuclear translocation of Nrf2 due to CSE (data not shown).
However, further studies on the exact mechanisms of action of these
antioxidant compounds are required.
CSE Increases Nrf2 and HO-1 Expression in ATI-like Cells
In order to confirm the observation of Nrf2 nuclear transloca-
tion in response to CSE in ATI-like cells as outlined above, we
analyzed Nrf2 and other ROS-sensitive or apoptosis-related
protein expression by western blotting. ATI-like cells were treated
with 1%, 5%, and 10% CSE for 4 h and 24 h. We observed early
statistically significant increases of Nrf2 (,98 kDa), HO-1
(32 kDa), and Hsp70 (70 kDa) after application 5% and 10%
CSE for 4 h (Figure 5A; Figure S2A). The highest expression was
observed for HO-1. We did not find significant expression of Fra1
(43 kDa) after cell treatment for 4 h. We also analyzed protein
expression after ATI-like cell treatment with CSE for 24 h
(Figure 5B; Figures S2B–E). Nrf2 and HO-1 expressions were
statistically significantly increased after application of all concen-
trations of CSE. Hsp70 expression was significantly increased after
treatment with 5% and 10% CSE, and Fra1 after 10% CSE
application. We found statistically significant higher expression of
Nrf2, HO-1 and Hsp70 in ATI-like cells in comparison with ATII
cells after cell treatment with 1% and 5% CSE (Figures S2, S3).
Our results suggest a role for ROS as mediators of CSE induced
stress response in ATI-like cells.
NAC and Trolox Increase Nrf2 Expression but ReduceHsp70
To determine whether application of NAC or trolox could
attenuate the CSE-induced cellular stress and Nrf2 expression, we
Figure 1. CSE induces apoptosis and necrosis in ATI-like cells. Panel I – Acridine orange and ethidium bromide double staining. A - Cells were
analyzed after 4 h treatment with 5% CSE. Live cells are green, late apoptotic cells have chromatin condensation (yellow) and necrotic cells are red; B -
Cells were treated with CSE for 4 h; C - Cells were exposed to CSE for 24 h. Data represent results from three independent experiments. Panel II -
TUNEL assay. A - Chromatin condensation in cells exposed to 5% CSE for 24 h; B – Chromatin fragmentation after cell treatment with 5% CSE for 24 h;
C - ATI-like cells were treated with CSE for 4 h and 24 h. Data represent results from three independent experiments (p,0.05). Panel III - Caspase 3
and caspase 7 activities. Cells were treated with CSE for 4 h and 24 h. Data are expressed in percentages of the control (p,0.05).
doi:10.1371/journal.pone.0026059.g001
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for 24 h. We found that 5 mM NAC or 5 mM trolox significantly
induced expression of Nrf2, which suggests a protective mecha-
nism of both antioxidant compounds against cell injury induced by
CSE (Figure 5C; Figure S2B). Moreover, we found that co-
treatment with CSE and NAC, or CSE and trolox for 24 h
significantly attenuated HO-1 (Figure S2C) and Hsp70 expression
(Figure S2D) induced by cell treatment with CSE. Collectively, our
data suggest the protective effect of NAC or trolox on the CSE-
induced cellular injury.
CSE Induces a Similar Response in Differentiated ATII
Cells but Requires a Higher Concentration
ATII cells are known to be less sensitive to oxidant injury than
type I cells in vivo and less sensitive to CSE (Figure S1). We
therefore wanted to determine if this was likely just due to the dose
or if the cellular response was totally different. Hence, we repeated
thesame studieswithdifferentiatedATIIcells.Wefoundstatistically
significant increases in Nrf2, HO-1, and Hsp70 expression in ATII
cells after 4 h and 24 h cell treatment with 5% and 10% CSE. We
also analyzed expression of proteins in ATII cells treated with CSE
for 4 h and 24 h (Figure 6A, B; Figure S3A, B). Fra1 expression was
significantly increased after 4 h treatment with 10% CSE and after
24 h treatment with 5% CSE. We did not observe statistically
significant increases in expression of all studied proteins after
application of 1% CSE after 4 h or 24 h. Furthermore, Nrf2
expression was significantly induced after 5% and 10% CSE was
added to ATII cells at 24 h and by all applied CSE concentrations
in ATI-like cells at the same time point (Figure S2). Only Nrf2
expression after treatment with 10% CSE was statistically higher in
ATII cells in comparison with ATI-like cells (Figure S3). However,
this suggests a decrease in Nrf2 activation under very high oxidative
stress [25,26] in ATI-like cells. In summary, ATI-like cells are more
sensitive especially after 24 h treatment with CSE than ATII cells
but the general response was similar.
Nrf2 Knockdown Sensitizes ATI-like Cells to Injury by CSE
We used Nrf2 overexpression or knockdown to provide a direct
link between CSE and Nrf2. We were able to knockdown Nrf2 in
ATI-like cells (Figure 7A, B). We found that cell transfection with
Nrf2 siRNA followed by exposure to 5% or 10% CSE induced a
significant increase in the percentage of necrotic cells in
comparison with CSE alone (Figure 7C). We did not observe a
statistically significant increase for 1% CSE. These results suggest
that Nrf2 knockdown sensitizes cells to CSE, which provides a
direct link between this gene and cell death.
Nrf2 Overexpression Protects ATI-like Cells Against Injury
by CSE
To complement studies described above, we used Nrf2
overexpression in ATI-like cells. We found that cell infection with
adenovirus Nrf2 (AdNrf2) followed by treatment with 5% or 10%
CSE significantly decreased the number of necrotic cells in
comparison with CSE alone (Figure 7D). We did not observe a
significant decrease for 1% CSE. This experiment confirms our
data on the protective role of Nrf2 in cells exposed to CSE.
NAC and Trolox Protect Cells with Knocked Down Nrf2
We knocked down Nrf2 in ATI-like cells followed by treatment
with CSE and NAC or trolox to verify the protective role of NAC
and trolox against CSE. We found a significantly lower percentage
of necrotic ATI-like cells after treatment with 5% CSE or 10%
CSE and NAC or trolox (Figure 8) in comparison with CSE alone.
Trolox but not NAC also protected cells treated with 1% CSE.
These results suggest that both antioxidant compounds may also
Figure 2. CSE produces 4-HNE in ATI-like cells. A - Control; B -
Cells exposed to 5% CSE for 24 h. Cells were probed by 4-HNE primary
antibody, stained with Alexa Fluor 488 as secondary antibody (green)
and mounted with Vectashield medium containing DAPI (blue). Shown
are representative images from three independent experiments.
doi:10.1371/journal.pone.0026059.g002
Figure 3. CSE induces nuclear localization of Nrf2 in ATI-like cells as detected by immunocytofluorescence. A - Cytoplasmic localization
of Nrf2 in control cells (red stain); B - Nuclear translocation of Nrf2 after 4 h treatment with 5% CSE. Representative data each from one of three
experiments are shown.
doi:10.1371/journal.pone.0026059.g003
Cell Injury Induced by Cigarette Smoke
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e26059Figure 4. NAC and trolox protect ATI-like cells treated with CSE. Cells were exposed to CSE or co-treated with CSE and NAC or CSE and trolox
for 24 h and toxicity was measured by propidium iodide and Hoechst 33342 double staining. A - Necrotic ATI-like cells after treatment with 5% CSE
for 24 h. B – Co-treatment with CSE and 5 mM NAC or CSE with 5 mM trolox for 24 h decreases the percentage of necrotic cells in comparison with
CSE alone. * - Statistically significant increase in percentage of necrotic cells induced by CSE, co-treatment with CSE and NAC or CSE and trolox in
comparison with control, NAC or trolox, respectively. # - Statistically significant decrease of ATI-like necrotic cells after co-treatment with CSE and
NAC or CSE and trolox in comparison with cell exposure to CSE. Data represent results from three independent experiments (p,0.05).
doi:10.1371/journal.pone.0026059.g004
Figure 5. Protein expression after treatment with CSE and effect of co-treatment with NAC or Tolox. Representative time and
concentration course expression of proteins in ATI-like cells exposed to CSE and after co-treatment with CSE and 5 mM NAC or CSE and 5 mM trolox.
Proteins were measured by immunoblotting. A - Cells treated for 4 h; B - Cells treated for 24 h; C - Cells were treated with CSE and NAC or trolox for
24 h. Representative data each from one of three experiments are shown.
doi:10.1371/journal.pone.0026059.g005
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pathways than Nrf2 and may directly neutralize the oxidant in
CSE or the initial ROS generated in cells exposed to CSE.
Discussion
Oxidative stress induced by CS plays a key role in the
pathogenesis of many pulmonary diseases [27]. However, the
toxicity has been variably attributed to apoptosis and necrosis. We
found that ATI-like cells are more sensitive to CS than
differentiated ATII cells. Since human type I cells have not been
isolated and cultured, we used ATI-like cells, which are type II
cells cultured to transdifferentiate into type I-like cells in vitro and
express a similar but slightly different gene profile to isolated type I
cells [23,28]. This study confirmed our hypothesis that Nrf2 plays
a direct role in preventing injury to alveolar epithelial cells by
CSE. Nrf2 overexpression protected cells and its knockdown
sensitized cells to CSE-induced cell death. Moreover, we also
found that NAC and trolox significantly decreased the percentage
of necrotic cells observed after treatment with CSE. Furthermore,
our results suggest that both antioxidant compounds may also
protect ATI-like cells against CSE through pathways other than
Nrf2.
We observed induction of both apoptosis and necrosis in a time-
and concentration-dependent manner after cell treatment with
CSE. We found a higher percentage of concentration-dependent
Figure 6. Time and concentration course expression of
proteins in ATII cells exposed to CSE. A - for 4 h; B - for 24 h.
Proteins were measured by immunoblotting. Representative data each
from one of three experiments are shown.
doi:10.1371/journal.pone.0026059.g006
Figure 7. Effect of Nrf2 knockdown and overexpression in ATI-like cells exposed to CSE. A – Nrf2 expression (immunoblotting); Lane 1 –
control; lane 2–300 nM NT siRNA; lane 3–300 nM Nrf2 siRNA; lane 4–200 MOI AdNrf2; lane 5–200 MOI AdGFP (see Materials and Methods); B -
Quantitation of Nrf2 relative protein expression in ATI-like for experiments shown in A. * - Statistically significant increase in protein expression
induced in comparison with negative control (p,0.05); C – Nrf2 knockdown sensitizes cells to CSE. Cells were transfected with Nrf2 siRNA for 24 h
followed by exposure to CSE for 24 h and toxicity was measured by propidium iodide and Hoechst 33342 double staining. D - Nrf2 overexpression
protects cells exposed to CSE. Cells were infected with AdNrf2 for 24 h, exposed to CSE for 24 h and necrotic cells were detected by Hoechst 33342
and propidium iodide double staining. * - Statistically significant increase in percentage of necrotic cells induced by CSE in comparison with control.
# - Statistically significant increase for C or decrease in D in ATI-like necrotic cells after transfection with Nrf2 siRNA or infection with AdNrf2,
respectively followed by CSE in comparison with CSE alone. Data represent results from three independent experiments (p,0.05).
doi:10.1371/journal.pone.0026059.g007
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treatment with CSE and more necrosis after 24 h cell treatment
with CSE. First, our results are in agreement with observations
that lung cell apoptosis tends to occur when CSE is applied for a
shorter time or at lower concentrations, whereas cells go into
necrosis when the CSE is given for a longer time or at higher
concentrations [2,29,30,31]. Second, we found that CSE de-
creased mitochondrial membrane potential in ATI-like cells after
24 h (Data S1; Figure S4A, B, C) and this may suggest that
dysfunctional mitochondria may enhance susceptibility to cell
death [32].
Moreover, a consequence of ROS production and the increased
oxidative stress response associated with CS is lipid peroxidation.
A specific end product of lipid peroxidation is 4-HNE, which can
react with DNA and proteins to generate various adducts that can
induce cellular response, including apoptosis [33]. We observed 4-
HNE positive ATI-like cells and intense staining in the cytoplasm
and nucleus. It was also reported that CSE increased 4-HNE levels
in human lung fibroblasts, and this staining was observed in the
cytoplasm, nucleus and in the nuclear membrane [33]. Thus lipid
peroxidation associated with increased ROS production may be
contributing to the CS-induced ATI-like cell apoptosis observed in
our studies.
Upon exposure to high concentrations of ROS found in CS,
lung tissue responds by activating the transcription of a battery of
genes that either aid in the detoxification of ROS or induce the
repair of the resulting intracellular oxidative damage [1]. We
observed significant Nrf2 expression in our studies with ATI-like
and ATII cells after exposure to CSE. Moreover, we found that
after ATI-like cell exposure to CSE, Nrf2 translocates to the
nucleus coinciding with significant expression of HO-1. We
observed the higher nuclear translocation of Nrf2 in ATI-like cells
treated with CSE for 4 h than for 24 h. It was suggested that at
this earlier time point, the oxidants in CSE oxidize the thiol group,
resulting in dissociation of Nrf2 from Keap1 and translocation of
Nrf2 into the nucleus. At 24 h CSE exposure, aldehydes present in
CSE or formed by lipid peroxidation form protein carbonyl
adducts with sulfhydryl (SH) groups of Nrf2/Keap1, thereby
leading to modulation of these groups [34].
We observed significant increases in Nrf2 and HO-1 expression
after ATI-like and ATII cell treatment with CSE for 4 h and 24 h.
The upregulation of HO-1 likely has a protective role to counteract
oxidative stress caused by CSE [27]. We also found significant
expression of Hsp70 and Fra1 afterATI-like and ATII cell exposure
to CSE. Increased expression of Hsp70 may represent a protective
mechanism against injury [35].
We also knocked down and overexpressed Nrf2 to analyze
its direct role in ATI-like cells exposed to CSE. We found that
Nrf2 overexpression protects cells and its knockdown sensitizes cells
to CSE-induced cell death. These results suggest the potential
importance of Nrf2 targeting to protect cells against CS. Further-
more, it has already been suggested that Nrf2 may be a potential
valuable therapeutic target in pulmonary emphysema [36].
NAC completely abolished the cytotoxicity of CSE in A549 cells
[30], attenuated ROS production and apoptosis induced by CSE
in three different human lung fibroblast strains [33] and
significantly decreased necrosis in our studies after co-treatment
with CSE and NAC in comparison with CSE alone. Moreover, Ji
et al. [37] found that NAC elevated Nrf2 expression significantly
in rat lungs. NAC protected against oxidative stress through acting
on Nrf2/glutathione reductase/GSH pathway, by which NAC
elevated the biosynthesis of protective GSH to repair and
reconstitute the defense system. This may explain the higher
expression of Nrf2 observed in our studies in ATI-like cells after
application of NAC. We observed significant attenuation of HO-1
expression after ATI-like cell co-treatment with CSE and NAC
that may suggest that NAC acts as a GSH precursor to raise
intracellular GSH level or as a thiol decoy, or both [38]. However,
we did not observe the decrease in Fra1 expression after CSE and
NAC cell co-treatment. This suggests that oxidative stress plays only
a minimal role in mediating CSE-stimulated fra1 induction. How-
ever, we observed significant decreases in expression of Hsp70 after
co-treatment with CSE and NAC in comparison with applica-
tion of CSE. Vayssier-Taussat [35] reported that pretreatment of
Figure 8. NAC and trolox protect ATI-like cells with knocked down Nrf2 against injury induced by CSE. Nrf2 was knocked down and
cells were exposed for 24 h to CSE and NAC or trolox and toxicity was measured by propidium iodide and Hoechst 33342 double staining.
* - Statistically significant increase in percentage of necrotic cells in comparison with control, NAC or trolox, respectively. # - Statistically significant
decrease of ATI-like necrotic cells after co-treatment with CSE and NAC or CSE and trolox in comparison with cell exposure to CSE. Data represent
results from three independent experiments (p,0.05).
doi:10.1371/journal.pone.0026059.g008
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CSE completely abolished CSE-mediated induction of Hsp70
expression by first, decreasing the stress responses induced by CSE
andsecond,byinhibitingtheintracellularGSHdepletionsecondary
to CSE exposure thus preventing lipid peroxidation.
Trolox prevents an increase in hydroxyl radical mediated
cytotoxcity, lipid peroxidation, and cell death [21,39,40]. We found
less necrosis after ATI-like cell co-treatment with CSE and trolox
than with CSE alone. We also observed a significant increase of
Nrf2 after ATI-like cell treatment with trolox. This compound,
possibly through the reduction of ROS, prevents the decrease in
GSH levels [41] and this may also explain the protective effect of
trolox in cells with knocked down Nrf2. We also observed that co-
treatment with CSE and trolox significantly decreased expression of
HO-1 in comparison to treatment with CSE alone. HO-1
expression was attenuated by co-treatment with CSE and trolox
or co-treatment with CSE and NAC. We did not observe HO-1
induction by NAC and trolox alone. HO-1 activation by Nrf2
represents a late event in the antioxidant response [42]. We also
observed a lower expression of all stress related proteins in ATII
cells treated with CSE as compared to ATI-like cells.
It was already reported that oxidative stress has been implicated
in the pathogenesis of pulmonary emphysema and CS is a major
causative factor in this disease’s development [13]. Studies using
Nrf2-knockout mice identified an extensive range of protective
roles for Nrf2 against pathogenesis of this disease [36,43]. Iizuka et
al. [44] reported that in Nrf2
2/
2 mice, emphysema was first
observed at 8 weeks and exacerbated by 16 weeks following CS-
exposure, whereas no pathological abnormalities were observed in
wild-type mice. Moreover, emphysema in Nrf2-deficient mice
exposed to CS for 6 months was associated with more pronounced
bronchoalveolar inflammation, oxidative stress in alveolar cells
and an increased number of apoptotic alveolar septal cells as
compared with wild-type mice. Furthermore, the expression of
nearly 50 Nrf2-dependent antioxidant and cytoprotective genes in
the lung were identified by microarray analysis that may work in
concert to counteract CS-induced oxidative stress and inflamma-
tion [43]. It is important to note that the potent Nrf2 activator,
CDDO-Im, significantly reduced lung oxidative stress, alveolar
cell apoptosis, alveolar destruction, and pulmonary hypertension
in wild-type mice caused by chronic exposure to CS. This
protection from CS-induced emphysema depended on Nrf2, as
Nrf2
2/
2 mice failed to show significant reduction in alveolar cell
apoptosis and alveolar destruction after treatment with this
compound. These results suggest that targeting the Nrf2 pathway
may represent an important approach for prophylaxis against
COPD [45]. Our results using human primary alveolar epithelial
cells improve our understanding of the protective role of Nrf2 in
CSE-induced injury. It is important to note that Nrf2 levels are
lower in lung tissue and alveolar macrophages from smoking-
related pulmonary emphysema [10,13,46]. Therefore antioxidant
compounds targeting Nrf2 may represent a potential therapeutic
strategy in this disease.
In summary, our study shows sensitivity of human alveolar
epithelial cells to CSE and the concept that Nrf2 activation is a
major cellular defense against CSE-induced oxidative stress. Our
results are in agreement with observations that ROS production
initiates the activation of Nrf2 and activated Nrf2 is recruited to
the promoter activity and the expression of HO-1 mRNA [47]. The
susceptibility of smokers to CS-dependent diseases may be based on
thedefensemechanismorchestrated byNrf2.Therefore antioxidant
agents that modulate Nrf2 would be expected to restore antioxidant
and detoxifying enzymes by upregulation of phase 2 genes,
counteract CS toxicity and to prevent of CS-related lung injury.
Our results suggest that both NAC and trolox can prevent the
cytotoxicity to human alveolar epithelial cells due to CSE.
Materials and Methods
Isolation and Culture of ATII Cells and ATI-like Cells
Deidentified human lungs not suitable for transplantation were
donated for medical research from the National Disease Research
Interchange (Philadelphia, PA) and the International Institute for
the Advancement of Medicine (Edison, NJ). In the present study
we selected donors with reasonable lung function with a PaO2/
FIO2 ratio of .250, a clinical history and x-ray that did not
indicate infection, and limited time on a ventilator. We know the
age, gender, race, smoking history, cause of death, very brief
medical history, and medications at the time of death. The
Committee for the Protection of Human Subjects at National
Jewish Health approved this research. In this study all the ATII
cells were isolated from 6 non-smokers.
The ATII cell isolation method has been published previously
[24]. Briefly, the right middle lobe was perfused, lavaged, and then
instilled with elastase (12.9 U/ml; Roche Diagnostics, Indianap-
olis, IN). The lung was minced and subsequently the cells were
filtrated and purified by centrifugation on a density gradient made
of Optiprep (Accurate Chemical Scientific Corp., Westbury, NY)
and by negative selection with CD14-coated magnetic beads
(Dynal Biotech ASA, Oslo, Norway) and binding to IgG-coated
(Sigma Chemicals Inc., St. Louis, MO) dishes. The cells were
counted and cell purity was estimated by staining for cytokeratin
CAM 5.2 (Dako, Carpinteria, CA). The purity of ATII cells was
,80% before plating and over 95% after adherence in culture
[23].
The isolated ATII cells were resuspended in DMEM supple-
mented with 10% fetal bovine serum (FBS; Thermo Scientific
HyClone, Franklin, MA), 2 mM glutamine (Thermo Scientific
HyClone, Franklin, MA), 2.5 mg/ml amphotericin B (Mediatech
Inc., Manassas, VA), 100 mg/ml streptomycin (Thermo Scientific
HyClone, Franklin, MA), 100 U/ml penicillin (Thermo Scientific,
Franklin, MA), and 10 mg/ml gentamicin (Sigma Chemicals Inc.,
St. Louis, MO). To maintain their differentiated state, ATII cells
were plated for 2 days on millicell inserts (Millipore Corp.,
Bedford, MA) that had been previously coated with a mixture of
20% Engelbreth-Holm-Swarm tumor matrix (BD Biosciences, San
Jose, CA) and 80% rat-tail collagen (RTC) in DMEM with 10%
FBS and then cultured for two days with 1% charcoal-stripped
FBS along with 10 ng/ml keratinocyte growth factor (R&D
Systems Inc., Minneapolis, MN), and for an additional two days
with 10 ng/ml keratinocyte growth factor, 0.1 mM isobutyl-
methylxanthine, 0.1 mM 8-Br-cAMP, and 10 nM dexamethasone
in addition to glutamine, amphotericin B, streptomycin, penicillin,
and gentamicin as mentioned above [24,48].
To transdifferentiate ATII cells into ATI-like cells, type II cells
were cultured on RTC-coated tissue culture plates, glass coverslips
or Lab-Tek chamber slides (Nalge Nunc International, Rochester,
NY). Cells were plated for two days in DMEM with 10% FBS and
subsequently cultured for four days in DMEM with 5% FBS [23].
Preparation of CSE
The CSE was prepared as previously described [49] with a
slight modification. Briefly, the smoke of one 3R4F cigarette
withoutfilter(Kentucky Tobacco Research& Development Center,
Lexington, KY) containing 9.5 mg tar and 0.72 mg nicotine [50]
was drawn into 12.5 ml DMEM with peristaltic pump (Man-
ostat 72-310-000; Barnant Company, Barrington, IL). The pump
was set at an optimum speed to allow one cigarette to burn in
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100% CSE. This solution was filtered through a 0.22 mm pore
acrodisc syringe filter and applied immediately to the cell cultures.
In our studies ATI-like cells and ATII cells were treated with 1%,
5%, and 10% CSE for 4 h and 24 h. Based on the published
assumption that a human generates 350 ml smoke with each
cigarette and hasa blood volumeof6 liters [51,52,53]we calculated
that in our studies 1% CSE is equal to 5 cigarettes/day, 5% CSE is
equal to 25 cigarettes/day and 10% CSE is equal to 50 cigarettes/
day which corresponds to the realistic situation of human daily
exposure to CS.
Chemical Compounds
Trolox (CAS 53188-07-1) was purchased from Calbiochem -
EMD Biosciences, Inc., La Jolla, CA and NAC (CAS 616-91-1)
from Sigma Chemicals Inc., St. Louis, MO. Trolox was dissolved
in ethanol and the final concentration of ethanol in the cultures
did not exceed 0.04% (v/v), and NAC was dissolved in PBS.
Identification of Apoptosis and Necrosis
a.) Acridine Orange and Ethidium Bromide Double
Staining. Double staining with acridine orange and ethidium
bromide (both from Sigma Chemicals Inc., St. Louis, MO) allows
to distinguish between: (i) living cells (green nucleus with red-
orange cytoplasm); (ii) early apoptosis stage (cell membrane still
continuous but chromatin condensation with an irregular green
nucleus is visible); (iii) late apoptosis (so called ‘secondary necrosis’
or ‘apoptotic necrosis’- orange nuclei, fragmentation or conden-
sation of chromatin is still observed); and (iv) necrosis (uniform
orange-coloured cell nuclei) [54]. 300 cells were immediately
analyzed and scored for these four stages by fluorescence mic-
roscopy (Zeiss Axiovert 200 M, Carl Zeiss, Germany) following the
addition of 4 mg/ml acridine orange and 4 mg/ml ethidium
bromide in three independent experiments.
b.) Hoechst 33342 and Propidium Iodide Double
Staining. Hoechst 33342 and propidium iodide (both from
Sigma Chemicals Inc., St. Louis, MO) at 0.01 mg/ml and
0.001 mg/ml respectively, were used to distinguish between live
and necrotic cells after treatment with CSE only, CSE and NAC or
CSE and trolox. 300 cells were analyzed by fluorescence micro-
scopy (Zeiss Axioskop 2, Carl Zeiss, Germany) in three independent
experiments.
c.) TUNEL Assay. The TdT-mediated dUTP Nick-End
Labeling (TUNEL; Promega, Madison, WI) assay was used to
compare the ability of CSE to induce apoptosis as previously
described [55]. Briefly, ATI-like cells were fixed in 4% para-
formaldehyde (Electron Microscopy Sciences, Hatfield, PA) in PBS
and permeabilized with 0.2% triton X-100 (Sigma Chemicals Inc.,
St. Louis, MO). Then, slides with cells were incubated for 1 h at
37uC in a humid chamber in the presence of terminal deoxy-
nucleotidyl transferase (TdT). In the negative control no TdT was
added whereas in the positive control 10 U/ml DNase (Promega,
Madison, WI) was used (data not shown), respectively according
to manufacturer’s recommendations. Cells were mounted with
Vectashield medium containing DAPI (Vector Laboratories,
Burlingame, CA) and analyzed by fluorescence microscopy (Zeiss
Axioskop 2, Germany). The percentage of TUNEL-positive apoptotic
ATI-like cells labeled with fluorescein (fluorescein-dUTP-labelled
DNA) was calculated per 10 high-power fields (magnification
10640) [56].
d.)Detection of Caspase 3 and Caspase 7 Activity. Con-
centration- and time-dependent caspase 3 and caspase 7 activities
were analyzed in ATI-like cells treated with CSE with a commercial
Caspase-Glo 3/7 Assay kit (Promega, Madison, WI). ATI-like cells
were treated with 1%, 5%, and 10% CSE for 4 h and 24 h, and
both attached and detached cells were collected for this assay. We
used 20,000 cells equilibrated to room temperature for this
experiment. Caspase-Glo 3/7 reagent was added for 1 h of incuba-
tion and then the luminescence signal was measured by a lumino-
meter (Synergy HT, BioTek) according to the manufacturer’s protocol.
Immunocytofluorescence
To detect Nrf2 translocation induced by CSE, NAC or trolox
ATI-like cells cultured on cover slips were fixed in 100% methanol
and washed in PBS. After blocking with 3% normal donkey serum
(Jackson ImmunoResearch; West Grove, PA) in PBS, the cells
were incubated with rabbit anti-Nrf2 (H-300) antibody (Santa
Cruz Biotechnology Inc., Santa Cruz, CA). The secondary
antibody, Alexa Fluor 594 anti-rabbit IgG (Invitrogen Corp.,
Carlsband, CA) was applied with the cells for 1 h, and cells were
mounted with Vectashield medium containing DAPI.
To analyze lipid peroxidation generated by CSE, ATI-like cells
were fixed in 4% paraformaldehyde, washed in PBS, permeabi-
lized 10 min in 0.2% Triton X-100, washed in PBS, and
subsequently blocked with 3% normal donkey serum in PBS.
Cells were incubated with a mouse monoclonal 4-hydroxy-2-
nonenal antibody (4-HNE; OXIS International Inc., Foster City,
CA). Subsequently, the secondary antibody, Alexa Fluor 488 anti-
mouse IgG (Invitrogen Corp., Carlsband, CA) was used, and cells
were mounted with Vectashield medium containing DAPI.
Western Blotting
ATI-like cells and ATII cells were treated with CSE for 4 h or
24 h. We also applied co-treatment of CSE and NAC or CSE and
trolox for 24 h in ATI-like cells. We collected both attached and
detached cells for this assay. Expression of protein was measured
by western blotting according to protocol described previously
[24]. Briefly, polyacrylamide gradient gels (8–16%; Invitrogen
Corp., Carlsband, CA) were run in tris glycine buffer to separate
the proteins. Protein loading was normalized to mouse anti-
glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH; 40 kDa)
purchased from Abcam (Cambridge, MA). Mouse anti-HO-1
(Hsp32) was purchased from Assay Designs (Ann Arbor, MI), and
the following antibodies were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA): mouse anti-Hsp70 (4E7), rabbit anti-
Nrf2 (H-300), and rabbit anti-Fra1 (R-20). Horseradish peroxidase
(HRP)-conjugated AffiniPure donkey anti-rabbit immunoglobulin
(Ig) G and HRP-conjugated AffiniPure donkey anti-mouse IgG
were purchased from Jackson ImmunoResearch (West Grove, PA).
The blots were then developed using an enhanced chemilumine-
sence western blotting kit according to the manufacturer’s instruc-
tions (Amersham Pharmacia Biotech, Piscataway, NJ). Images were
quantitated using NIH Image 1.62 software.
Nrf2 Overexpression
AdNrf2 and adenovirus green fluorescent protein (AdGFP) were
obtained from Dr. Timothy H. Murphy [57]. ATI-like cells were
infected by adenovirus diluted to a multiplicity of infection (MOI)
of 200 in PBS. Cells were allowed to express transgenes for 24 h
before treatment with CSE. All infected cell cultures were examined
for adequate infection efficiency (86%) as assessed by GFP fluo-
rescence and by western blotting.
Nrf2 Knockdown
Nrf2 siRNA (small inhibitory RNA) duplex showing maximum
knockdown in A549 cells (sense: 59 CAGCAGAACUGUACCU-
GUUUU 39; antisense: 39 UUGUCGUCUUGACAUGGACAA
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CO). To confirm the specificity of the inhibition, the control,
nontargeting siRNA was used as negative control (sense: 59
UAGCGACUAAACACAUCAAUU 3; antisense 39 UUAUCG-
CUGAUUUGUGUAGUU 59) [58]. Cells were transfected with
300 nM of siRNA duplexes by using GenomONE HVJ Envelope
Vector Kit (Cosmo Bio CO. Ltd. Carlsbad, CA) according to the
manufacturer’s recommendations. After 24 h, cells were treated
with CSE as described above. Knockdown of the target gene was
quantified by western blotting.
We also knocked down Nrf2 (24 h) followed by treatment with
CSEand NACortroloxfor24 h asdescribedabove.Thisapproach
was used to verify the direct link between Nrf2, CSE and NAC or
trolox.
Statistical analysis
One-way ANOVA by GraphPad Prism 4 was used to evaluate
statistical differences among experimental groups. A Dunnett’s test was
applied and a value of p,0.05 was considered significant. Data are
shown here as the mean 6SEM from three independent experiments.
Supporting Information
Figure S1 ATII cells are more resistant to CSE than ATI-
like cells as detected by Hoechst 33342 and propidium
iodide double staining. A - ATI-like cells were analyzed after
4 h and 24 h treatment with CSE; B - ATII cells were treated with
CSE for 4 h and 24 h. * - Statistically significant increase in
percentage of necrotic cells induced by CSE in comparison with
control. # - Statistically significant increase of ATI-like necrotic
cells in comparison with necrotic ATII cells after treatment with
CSE. Data represent results from three independent experiments
(p,0.05).
(TIF)
Figure S2 Time and concentration course expression of
proteins in ATI-like cells. ATI-like cells were treated with
CSE or cotreated with CSE and NAC or CSE and trolox. Proteins
were measured by immunoblotting using NIH Image 1.62
software. A - Quantitation of Nrf2, HO-1, Hsp70 and Fra1
relative protein expression after ATI-like cell treatment with CSE
for 4 h for experiments shown in Figure 5A. Quantitation of Nrf2
(B), HO-1 (C), Hsp70 (D) and Fra1 (E) protein levels relative to
GAPDH were measured after ATI-like cell treatment with CSE
for 24 h, cotreatment for 24 h with CSE and NAC or CSE and
trolox for experiments shown in Figure 5B, C. * - Statistically
significant increase in protein expression induced by CSE in
comparison with negative control. # - Statistically significant
decrease in HO-1 and Hsp70 protein expression after ATI-like cell
cotreatment with CSE and NAC or CSE and trolox in comparison
with CSE. 1 - Statistically significant increase in protein expression
in ATI-like cells in comparison with results for ATII cells presented
in Figure S3. All experiments were repeated three times (p,0.05).
(TIF)
Figure S3 Time and concentration course expression of
proteins in ATII cells. ATII cells were treated with CSE for
4 h and 24 h. Proteins were measured by immunoblotting using
NIH Image 1.62 software. A - Quantitation of Nrf2, HO-1, Hsp70
and Fra1 relative protein expression after ATII cell treatment with
CSE for 4 h for experiments shown in Figure 6A. B - Quantitation
of Nrf2, HO-1, Hsp70 and Fra1 relative protein expression after
ATII cell treatment with CSE for 24 h for experiments shown in
Figure 6B. * - Statistically significant increase in protein expression
induced by CSE in comparison with negative control. 1 - Statistically
significantdifferencesinproteinexpressionincomparisonwithresults
for ATI-like cells presented in Figure S2. All experiments were
repeated three times (p,0.05).
(TIF)
Figure S4 CSE reduces the mitochondrial membrane
potential in ATI-like cells. A – In control cells a red multimeric
form of dye accumulates in healthy mitochondria as detected by the
DePsipher
TM assay. The green monomeric form of the dye in
cytoplasm is observed when mitochondrial membrane collapses in
apoptotic cells after incubation with 3 mM valinomycin for 24 h (B)
or after exposure to 5% CSE for 24 h (C). Representative data each
from one of three experiments are shown.
(TIFF)
Data S1 Supplementary data.
(DOC)
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